variations in excretion of S. typhosa.* This examination continued at weekly intervals for one month during and after treatment to ascertain the extent and duration of any suppression of typhoid organisms which might result.
Samples of bile obtained by duodenal intubation before and during chloramphenicol therapy were also examined bacteriologically. At each intubation 5 to 20 ml. volumes of duodenal contents were aspirated at 5-, 15-, and 25-minute intervals after delivery into the duodenum of 60 ml. of a 50 per cent magnesium sulfate solution. All samples were examined bacteriologically and were assayed for the presence of active chloramphenicol.
Counts of S. typhosa in fresh stool and bile were determined by inoculating liquid Difco bismuth sulfite with 10-fold dilutions of feces or bile. Each dilution was delivered in 4.5 ml. quantities into each of two petri dishes, and 20 ml. of liquid bismuth sulfite agar were then added and mixed well by swirling. The black Salmonella colonies were counted after incubation for 48 hours at 37°C., and the highest dilution of inoculum which produced one to thirty colonies was recorded as the end point. Colonies from these end-point plates were identified periodically by phage typing, cultural studies, and slide agglutination tests.
Sensitivity of the S. typhosa strains isolated from these patients was determined with respect to chloramphenicol by two techniques. In one, an 18-hour broth culture of the organism was streaked on plates of nutrient agar containing 1.56, 2.56, 3.12, 12.5, and 25.0 micrograms/ml. of crystalline chloramphenicol. In the second technique, an 18-hour broth culture of freshly isolated S. typhosa was diluted to 10-8 and added in 1.5 ml. portions to tubes containing varying concentrations of crystalline antibiotic in 0.5 ml. of broth, so that the final concentrations of chloramphenicol were 1.87, 2.33, 3.12, 4.67, 6.25, 9.4, and 12.5 micrograms/ml. The lowest concentration of antibiotic at which no growth was visible after incubation for 24 hours at 370 C. was recorded as the level of sensitivity of the organism by the method employed.
The quantity of chloramphenicol in serum, bile, and urine was determined periodically during treatment. A modificationt of the method of Joslyn and Galbraith7"1 was employed, in which an 18-hour broth culture of S. sonnei diluted to 1.5 by 10-8 in broth was added in 1.5 ml. volumes to samples of body fluids which had been diluted serially in broth and transferred to the culture tubes in 0.5 ml. quantities. Inhibition of growth of the test organism by the body fluids was determined visually after incubation for 18 hours at 300 C. Identical inocula of the diluted S. soninei culture were added to a series of tubes containing 0.5 ml. volumes of crystalline chloramphenicol in broth in quantities such that the final concentrations of the antibiotic were 0.233, 0.312, 0.467, 0.625, 0.940, and 1.25 micrograms/ml. The quantity of chloramphenicol in each sample of body fluid was then determined by multiplying the lowest dilution of the sample that caused complete inhibition of S. sonnei by the number of micrograms per milliliter of chloramphenicol in the first tube of the standard series in which complete inhibition was observed. Chloramphenicol was administered in gelatin capsules in a total daily dose of 3.75 grams, given on a schedule of 0.75 gram every four hours for five doses, in a program of self-administration. Treatment continued for 15 days (R.L.) and 19 days (E.G.), with certain departures from the original dosage schedule required by the appearance of untoward reactions, presumably due to the antibiotic. Thus, patient E.G. followed the 3.75 gram per day schedule with one 30-hour lapse during the sixth and seventh days of treatment; and patient R. L. adhered to the initial schedule until the tenth day, at which time the dosage was reduced to 2.25 grams a day. In the treatment of the latter patient the dosage was further reduced to 2 grams a day from the twelfth to the fifteenth day of treatment. Even with the reduced dosage, the schedule of five daily doses at 4-hour intervals was retained. In terms of body weight these dosages represented 33 mg./kg./day for 19 days (E.G.); and 44 mg./kg./day for 9 days, 26 mg./kg./day for 2 days, and 23 mg./kg./day for 4 days (R.L.).
Results
Salmonella typhosa, Vi form, bacteriophage types E1 (patient E.G.) and F2 (patient R.L.), were consistently isolated from fecal and bile samples.
The concentrations of typhoid bacilli in fecal samples, summarized in Figure 1 , were generally high and fluctuated over a ten-fold range (R.L.) or a hundred-fold range (E.G.) during the pretreatment study of each patient. An exception is evident in the first stool sample from E. G., which was negative, probably through technical error.
During chloramphenicol administration, the S. typhosa counts in stool specimens from R. L. on one occasion dropped one thousand-fold below the counts observed during the immediate pretreatment period. Only a tenfold decrease in numbers of S. typhosa was observed in bile obtained during treatment. Excretion of S. typhosa in the stools of this patient returned to pretreatment levels immediately after cessation of therapy. The concentration of typhoid bacilli observed in the feces of patient E. G. during antibiotic administration was depressed briefly only ten-fold below the lowest pretreatment level. One sample of bile showed considerable numbers of organisms during the treatment period.
Serum and urine levels of chloramphenicol were, in general, at the lower limit of the range to be expected from the dosage used in this trial ( Table  1) . The antibiotic was present in amounts varying from 1.87 to 7.4 micrograms/ml. in serum obtained 8 hours after completion of one day of treatment. This should represent the lowest serum level occurring in any 24-hour period during treatment. Chloramphenicol content of bile varied from none to 2.5 micrograms/ml. in patient E. G., and was zero in patient R. L. All specimens of bile obtained at each intubation were tested.
Sensitivity of the S. typhosa strains studied in this trial varied according to the technique employed. On agar plates containing chloramphenicol the limit of sensitivity was 3.12 micrograms/ml.; in broth tubes containing chloramphenicol it was 1.87 micrograms/ml. No alteration in sensitivity of either strain of S. typhosa was observed by these methods before, during, or after therapy.
Untoward oral reaction. Intense pain and swelling of the oral mucous membranes, with dysphagia, rawness, burning of the tongue, and bitter tasting saliva, accompanied by anorexia, occurred in both patients during chloramphenicol administration. The symptoms of these reactions were first noted on the fifth day (E.G.) and the seventh day (R.L.) of therapy. In both patients the tongue was beefy red, with smooth lateral borders and hypertrophied papillae. Examination also revealed edema and marked reddening of the soft palate and buccal and pharyngeal mucosae. Both patients developed cheilosis of one corner of the mouth soon after the first signs appeared. Mucosal ulcerations or exudate were absent and the gums were not involved. Neither patient demonstrated skin lesions, tendon reflex changes, alterations in number or character of red or white blood cells, urinary abnormalities, or diarrhea. In patient E. G. there was an initial low fever, cervical adenopathy, and elevation of the white blood cell count. No pathogens were found in bacteriological cultures of scrapings from this patient's oral and pharyngeal mucosa, but numerous fusospirochaetal organisms were discovered on microscopic examination of a stained smear. Penicillin, 300,000 units a day for two days, administered parenterally, effected prompt relief of fever, cervical adenitis, and pharyngeal soreness, but did not alter the red, painful lingual and buccal mucosal reaction. Niacinamide, given orally in 100 mg. daily doses for three days (E.G.), or concentrated B complex vitamins, given parenterally and orally for four days (R.L.), were administered while antibiotic treatment continued. All symptoms, except the bitter taste of the saliva, were relieved in both patients within 24 hours, and objective findings were markedly reduced in 48 hours. The clinical signs disappeared completely by the fourth to fifth day after vitamin administration was begun, although chloramphenicol therapy was continued.
Summary and conclusions Two chronic typhoid carriers showed high, nearly constant levels of excretion of phage types E1 or F2 of S. typhosa during 14 weekly examinations of feces prior to treatment with chloramphenicol. The bile of both carriers, obtained by duodenal intubation, contained large numbers of typhoid bacilli on at least one occasion. Only slight suppression of the fecal excretion of S. typhosa was noted during treatment with chloramphenicol, and the large quantities of typhoid bacilli observed originally were found in the feces immediately after cessation of therapy. This confirms the observations of other investigators who report little effect by chloramphenicol upon the typhoid carrier state.
An untoward oral reaction, resembling that caused by vitamin B deficiency, appeared in one patient within five days, and in the other within seven days after initiation of oral administration of chloramphenicol. Reduction of dosage for one patient did not influence the reaction. When niacinamide or a multiple B vitamin preparation was administered, prompt improvement of the oral reaction occurred while chloramphenicol administration was continued. Similar amelioration of these side effects of chloramphenicol have been reported by Harris. Although neither patient had shown clinical evidence of vitamin B deficiency before treatment, the diet of one patient had been insufficient in vitamins of the B group, and the diet of the other had been marginal in this regard. It is possible that their dietary backgrounds contributed to the untoward reactions experienced by these patients.
